Litigation funder
Drug Price Antitrust Finance Co (DPAF)
Listed in Washington DC, United States.
Publicly reported facts
Location
Washington DC, United States
Region
North America
Year founded
2017
Status
Active (reported)
Publicly listed
No
AUM or fund size
$150M+
Minimum investment
$2M+
Case types
Drug price-fixing antitrust claims, Pharmaceutical antitrust litigation, Generic drug cartel claims, Pay-for-delay litigation
Geographic coverage
USA
Information as publicly reported; confirm terms directly with the funder. Criterica Capital does not endorse any listed funder.
Comparing funders? Criterica Capital publishes its pricing and gives decisions in 24 to 48 hours.
Get a competing quote from Criterica CapitalMore in the directory